National Research Debt to Equity

National Research (NRC) currently reports a debt-to-equity ratio of 16.3. That is above the Healthcare sector average of 0.26. Use the charts on this page to explore National Research's debt-to-equity ratio history and peer comparisons.

National Research's debt-to-equity ratio of 16.3 is higher than the Healthcare sector average of 0.26. That is roughly 6067.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The debt-to-equity ratio is a valuation multiple that relates National Research's market price to a fundamental measure such as earnings, sales, or book value. At 16.3, NRC can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current debt-to-equity ratio of 16.3, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 0.26. From there, open related valuation or income-statement pages for National Research, and consider following NRC for alerts when major investors trade the stock.

National Research is classified in the Healthcare sector. On debt-to-equity ratio, it currently shows 16.3 versus a sector average near 0.26. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NRC with unrelated industries.